An ambitious eight-year international research initiative between the University of Dundee and Germany's Max Planck Institute explores cellular mechanisms that function like biological switches. This groundbreaking collaboration aims to unlock how these molecular regulators control cellular behavior and disease progression. The findings could revolutionize oncology by identifying new therapeutic targets and developing innovative treatment strategies specifically designed to interrupt cancer cell growth and proliferation at the molecular level.

Summary auto-generated by AI from the original publisher's content. Editorial standards.